ARTICLE | Company News
cSens, Biovica deal
May 23, 2016 7:00 AM UTC
Biovica acquired fellow diagnostic company cSens in a “non-cash issue.” cSens’ PCR-based platform analyzes serum thymidine kinase enzyme activity to measure tumor and cancer progression. cSens did not...